Your browser doesn't support javascript.
loading
Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018.
Cook, Sam; Pethick, Joanna; Kibbi, Nour; Hollestein, Loes; Lavelle, Katrina; de Vere Hunt, Isabella; Turnbull, Clare; Rous, Brian; Husain, Akhtar; Burn, John; Lüchtenborg, Margreet; Santaniello, Francesco; McRonald, Fiona; Hardy, Steven; Linos, Eleni; Venables, Zoe; Rajan, Neil.
Afiliação
  • Cook S; Department of Pathology, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
  • Pethick J; National Disease Registration Service (NDRS), NHS Digital, London, United Kingdom.
  • Kibbi N; Department of Dermatology, Stanford University School of Medicine, Stanford, California.
  • Hollestein L; Department of Dermatology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; Department of Research, Netherlands Comprehensive Cancer Center (IKNL), Utrecht, The Netherlands.
  • Lavelle K; National Disease Registration Service (NDRS), NHS Digital, London, United Kingdom.
  • de Vere Hunt I; Department of Dermatology, Stanford University School of Medicine, Stanford, California.
  • Turnbull C; National Disease Registration Service (NDRS), NHS Digital, London, United Kingdom.
  • Rous B; National Disease Registration Service (NDRS), NHS Digital, London, United Kingdom.
  • Husain A; Department of Pathology, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
  • Burn J; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Lüchtenborg M; National Disease Registration Service (NDRS), NHS Digital, London, United Kingdom; Centre for Cancer, Society & Public Health, Comprehensive Cancer Centre, King's College London, London, United Kingdom.
  • Santaniello F; National Disease Registration Service (NDRS), NHS Digital, London, United Kingdom; Health Data Insight, Cambridge, United Kingdom.
  • McRonald F; National Disease Registration Service (NDRS), NHS Digital, London, United Kingdom.
  • Hardy S; National Disease Registration Service (NDRS), NHS Digital, London, United Kingdom.
  • Linos E; Department of Dermatology, Stanford University School of Medicine, Stanford, California.
  • Venables Z; National Disease Registration Service (NDRS), NHS Digital, London, United Kingdom; Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, United Kingdom; Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
  • Rajan N; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom. Electronic address: neil.rajan@ncl.ac.uk.
J Am Acad Dermatol ; 89(6): 1129-1135, 2023 12.
Article em En | MEDLINE | ID: mdl-37031776
ABSTRACT

BACKGROUND:

Sebaceous carcinomas (SC) may be associated with the cancer predisposition syndrome Muir-Torre/Lynch syndrome (MTS/LS), identifiable by SC mismatch repair (MMR) screening; however, there is limited data on MMR status of SC.

OBJECTIVE:

To describe the epidemiology of SC, copresentation of other cancers, and population level frequency of MMR screening in SC.

METHODS:

A population-based retrospective cohort study of SC patients in the National Cancer Registration and Analysis Service in England.

RESULTS:

This study included 1077 SC cases (739 extraocular, 338 periocular). Age-standardized incidence rates (ASIR) were higher in men compared with women, 2.74 (95% CI, 2.52-9.69) per 1,000,000 person-years for men versus 1.47 person-years (95% CI, 1.4-1.62) for women. Of the patients, 19% (210/1077) developed at least one MTS/LS-associated malignancy. MMR immunohistochemical screening was performed in only 20% (220/1077) of SC tumors; of these, 32% (70/219) of tumors were MMR deficient.

LIMITATIONS:

Retrospective design.

CONCLUSIONS:

Incorporation of MMR screening into clinical practice guidelines for the management of SC will increase the opportunity for MTS/LS diagnoses, with implications for cancer surveillance, chemoprevention with aspirin, and immunotherapy treatment targeted to MTS/LS cancers.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias das Glândulas Sebáceas / Carcinoma Basocelular / Neoplasias Colorretais / Neoplasias de Anexos e de Apêndices Cutâneos / Adenocarcinoma Sebáceo / Síndrome de Muir-Torre Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias das Glândulas Sebáceas / Carcinoma Basocelular / Neoplasias Colorretais / Neoplasias de Anexos e de Apêndices Cutâneos / Adenocarcinoma Sebáceo / Síndrome de Muir-Torre Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article